News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CMSI Expects LT Growth for MAO GEPING (01318.HK), Initiates Coverage w/ Rating Overweight
CMSI released a research report expecting that MAO GEPING (01318.HK)'s revenue will grow from RMB3.9 billion in 2024 to RMB9.8 billion in 2027, driven by star products, achievi...
Reset
Send
The window will close in 5 seconds
<Research>CMSI Expects LT Growth for MAO GEPING (01318.HK), Initiates Coverage w/ Rating Overweight
Close
Recommend
4
Positive
11
Negative
6
 
SHORT SELL
 
STOCK INFO

CMSI released a research report expecting that MAO GEPING (01318.HK)  -0.600 (-0.599%)    Short selling $11.44M; Ratio 10.889%   's revenue will grow from RMB3.9 billion in 2024 to RMB9.8 billion in 2027, driven by star products, achieving a CAGR of 36%, mainly attributed to the maturation of star products and the synergies between different business segments.

CMSI initiated coverage on MAO GEPING, with rating at Overweight and a target price of $102.4, based on a mid-2026 projected PE ratio of 38.5x.

If MAO GEPING follows the development path of Estee Lauder Companies (EL.US)      , completing regional brand acquisitions and establishing a pan-Asian high-end positioning in the future, it could further increase its valuation to a PE ratio level of 50x, thereby better supporting its skincare business share and profit margin performance, the broker added.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-01 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.